← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #959 OF 1,000 MOST-CITED

Proper pH controls

FDA cited this observation 18 times across 18 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods18
BY FISCAL YEAR
FY20191
FY20182
FY20177
FY20168

How FDA worded it — real examples

Failure to adequately monitor pH for foods that rely principally on the control of pH to prevent the growth of undesirable microorganisms.

Get Drizzled Custom Wine Drizzle, LLC · Mayview, Missouri · Foods · 2019-04-23

Failure to adequately monitor pH for foods that rely principally on the control of pH to prevent the growth of undesirable microorganisms.

Planet Health Packaging, Inc. · Port Jervis, New York · Foods · 2018-03-01

Failure to adequately monitor pH for foods that rely principally on the control of pH to prevent the growth of undesirable microorganisms.

Buffalo Mountain Kombucha · Floyd, Virginia · Foods · 2018-02-08

Failure to adequately monitor pH and maintain a pH of 4.6 or below for foods that rely principally on the control of pH to prevent the growth of undesirable microorganisms.

TSUKEZEN SHOTEN CO., LTD. KOBE IND. · Kobe · Foods · 2017-09-05

Failure to adequately monitor pH for foods that rely principally on the control of pH to prevent the growth of undesirable microorganisms.

Wake Robin Fermented Foods LLC. · Cleveland, Ohio · Foods · 2017-07-17

Failure to adequately monitor pH for foods that rely principally on the control of pH to prevent the growth of undesirable microorganisms.

United Farm Processing Corp · Rosenhayn, New Jersey · Foods · 2017-07-14

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →